HGH Eins Ltd 12784513 false 2025-07-01 2026-07-31 2026-07-31 The principal activity of the company is investment holding. Digita Accounts Production Advanced 6.30.9574.0 true 12784513 2025-07-01 2026-07-31 12784513 2026-07-31 12784513 bus:OrdinaryShareClass1 2026-07-31 12784513 core:CurrentFinancialInstruments 2026-07-31 12784513 core:CurrentFinancialInstruments core:WithinOneYear 2026-07-31 12784513 core:FurnitureFittingsToolsEquipment 2026-07-31 12784513 bus:SmallEntities 2025-07-01 2026-07-31 12784513 bus:AuditExemptWithAccountantsReport 2025-07-01 2026-07-31 12784513 bus:FilletedAccounts 2025-07-01 2026-07-31 12784513 bus:SmallCompaniesRegimeForAccounts 2025-07-01 2026-07-31 12784513 bus:RegisteredOffice 2025-07-01 2026-07-31 12784513 bus:Director1 2025-07-01 2026-07-31 12784513 bus:Director2 2025-07-01 2026-07-31 12784513 bus:OrdinaryShareClass1 2025-07-01 2026-07-31 12784513 bus:PrivateLimitedCompanyLtd 2025-07-01 2026-07-31 12784513 bus:Agent1 2025-07-01 2026-07-31 12784513 core:FurnitureFittingsToolsEquipment 2025-07-01 2026-07-31 12784513 countries:England 2025-07-01 2026-07-31 12784513 2025-06-30 12784513 core:FurnitureFittingsToolsEquipment 2025-06-30 12784513 2024-07-01 2025-06-30 12784513 2025-06-30 12784513 bus:OrdinaryShareClass1 2025-06-30 12784513 core:CurrentFinancialInstruments 2025-06-30 12784513 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 12784513 core:FurnitureFittingsToolsEquipment 2025-06-30 12784513 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2025-06-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12784513

HGH Eins Ltd
Annual Report and Unaudited Financial Statements
for the Period from 1 July 2025 to 31 July 2026

HGH Eins Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 7

HGH Eins Ltd

Company Information

Directors | C McMullen E D Charles

Registered office | Elsted Green Elsted Midhurst GU29 0JU

Accountants | Tax Innovations Limited Innovations House 19 Staple Gardens Winchester Hampshire SO23 8SR

HGH Eins Ltd

(Registration number: 12784513)
Balance Sheet as at 31 July 2026

| Note | 2026 £ | 2025 £
Fixed assets |  |  |
Tangible assets | 4 | - | 4,156
Current assets |  |  |
Debtors | 5 | 25,694 | 129,801
Cash at bank and in hand |  | 5,053 | 188,757
|  | 30,747 | 318,558
Creditors: Amounts falling due within one year | 6 | (30,714) | (37,995)
Net current assets |  | 33 | 280,563
Net assets |  | 33 | 284,719
Capital and reserves |  |  |
Called up share capital | 7 | 100 | 100
Other reserves |  | 372,040 | 162,280
Retained earnings |  | (372,107) | 122,339
Shareholders' funds |  | 33 | 284,719

For the financial period ending 31 July 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 12 August 2026 and signed on its behalf by:

......................................... C McMullen Director

HGH Eins Ltd

Notes to the Unaudited Financial Statements for the Period from 1 July 2025 to 31 July 2026

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Elsted Green
Elsted
Midhurst
GU29 0JU

These financial statements were authorised for issue by the Board on 12 August 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
- the amount of revenue can be reliably measured;
- it is probable that future economic benefits will flow to the entity; and
- specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

HGH Eins Ltd

Notes to the Unaudited Financial Statements for the Period from 1 July 2025 to 31 July 2026

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

HGH Eins Ltd

Notes to the Unaudited Financial Statements for the Period from 1 July 2025 to 31 July 2026

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the period, was 3 (2025 - 3).

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 July 2025 | 7,115 | 7,115
Disposals | (7,115) | (7,115)
At 31 July 2026 | - | -
Depreciation
At 1 July 2025 | 2,959 | 2,959
Charge for the period | 1,927 | 1,927
Eliminated on disposal | (4,886) | (4,886)
At 31 July 2026 | - | -
Carrying amount
At 31 July 2026 | - | -
At 30 June 2025 | 4,156 | 4,156

5 | Debtors

HGH Eins Ltd

Notes to the Unaudited Financial Statements for the Period from 1 July 2025 to 31 July 2026

Current | Note | 2026 £ | 2025 £
Trade debtors |  | - | 48,993
Amounts owed by related parties | 8 | - | 10,028
Other debtors |  | 25,694 | 70,780
|  | 25,694 | 129,801

6 | Creditors

Creditors: amounts falling due within one year

| 2026 £ | 2025 £
Due within one year |  |
Trade creditors | - | 1,326
Taxation and social security | 1,565 | 25,594
Accruals and deferred income | 1,800 | 8,459
Other creditors | 27,349 | 2,616
| 30,714 | 37,995

7 | Share capital

Allotted, called up and fully paid shares

| 2026 | 2025
| No. | £ | No. | £
Ordinary of £1 each | 100 | 100 | 100 | 100

HGH Eins Ltd

Notes to the Unaudited Financial Statements for the Period from 1 July 2025 to 31 July 2026

8 | Related party transactions

Directors' remuneration

The directors' remuneration for the period was as follows:

| 2026 £ | 2025 £
Remuneration | 165,750 | 153,544

Income and receivables from related parties

2026

2025 | Key management £
Amounts receivable from related party | 10,028